SCHEMBL2288062

SCHEMBL2288062

O=c1[nH]c(=S)n(C[C@H]2CCCO2)c2nc[nH]c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPO P05164 6/20 1.00
▸ TPO P07202 4/20 1.00
▸ ALDH1A1 P00352 9/20 0.48
▸ POLB P06746 1/20 0.48
▸ HSD17B10 Q99714 4/20 0.48
▸ GAA P10253 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ TSHR P16473 2/20 0.46
▸ KDM4E B2RXH2 3/20 0.44
▸ CASP1 P29466 1/20 0.44
▸ CASP7 P55210 1/20 0.44
▸ PDE4A P27815 2/20 0.44
▸ ADORA2A P29274 2/20 0.44
▸ PDE4B Q07343 2/20 0.44
▸ PDE4C Q08493 2/20 0.44
▸ PDE4D Q08499 2/20 0.44
▸ MAPK1 P28482 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ ADORA2B P29275 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2280952 1.00 MPO (1.00) MPOTPOALDH1A1POLBHSD17B10
SCHEMBL1960671 1.00 MPO (1.00) MPOTPOALDH1A1POLBHSD17B10
SCHEMBL1461291 0.82 MPO (0.70) MPOTPOALDH1A1HSD17B10PDE4A
SCHEMBL1460900 0.81 MPO (0.69) MPOTPOALDH1A1HSD17B10KDM4E
SCHEMBL29084974 0.76 MPO (0.61) MPOTPOALDH1A1POLBHSD17B10
SCHEMBL1962177 0.75 MPO (0.59) MPOTPOALDH1A1POLBHSD17B10
SCHEMBL3256669 0.75 MPO (0.59) MPOTPOALDH1A1POLBHSD17B10
SCHEMBL1959309 0.72 MPO (0.56) MPOTPOALDH1A1POLBHSD17B10
SCHEMBL10180927 0.71 MPO (0.60) MPOTPOHSD17B10PDE4AADORA2A
SCHEMBL1373494 0.71 PDE4A (0.74) MPOTPOHSD17B10PDE4AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12435292-B2 Anti-corrosive lubricant composition for electrical apparatus HENKEL AG & CO. KGAA (DE) 2025-10-07 — — US claimed
US-12383158-B2 Detection of high-risk unstable atherosclerotic plaque THE HEART RESEARCH INSTITUTE LTD (AU) 2025-08-12 — — US claimed
CN-120137627-A Paraffin asphalt double-effect composite blocking remover and preparation method thereof 西南石油大学 2025-06-13 — — CN claimed
EP-4479498-A1 ANTI-CORROSIVE LUBRICANT COMPOSITION FOR ELECTRICAL APPARATUS Henkel AG & Co. KGaA (DE) 2024-12-25 — — EP claimed
US-20240392205-A1 ANTI-CORROSIVE LUBRICANT COMPOSITION FOR ELECTRICAL APPARATUS HENKEL AG & CO. KGAA (DE) 2024-11-28 — — US claimed
CN-118715309-A Corrosion resistant lubricating oil composition for electrical equipment 汉高股份有限及两合公司 2024-09-27 — — CN claimed
CN-118531636-A High-temperature-resistant emulsion sizing agent and preparation method and application thereof 中复神鹰碳纤维股份有限公司 2024-08-23 — — CN claimed
US-20240138701-A1 DETECTION OF HIGH-RISK UNSTABLE ATHEROSCLEROTIC PLAQUE THE HEART RESEARCH INSTITUTE LTD (AU) 2024-05-02 — — US claimed
WO-2024031149-A1 METHODS FOR THE DETECTION OF MYELOPEROXIDASE THE UNIVERSITY OF SYDNEY (AU) 2024-02-15 — — WO claimed
CN-116770591-A Polyetherimide aqueous emulsion sizing agent, preparation method thereof and carbon fiber 中复神鹰碳纤维股份有限公司 2023-09-19 — — CN claimed
US-20220160715-A1 MPO INHIBITORS FOR USE IN MEDICINE ASTRAZENECA AB (SE) 2022-05-26 — — US claimed
CN-113249095-B Preparation method of double-layer shell nano microcapsule with energy storage and anticorrosion functions 上海儒熵新能源科技有限公司 2022-05-10 — — CN claimed
CN-114257186-A 5G millimeter wave radio frequency power amplifier based on efficient DPD predistortion algorithm 蒋永彬 2022-03-29 — — CN claimed
US-11246870-B2 MPO inhibitors for use in medicine ASTRAZENCA AB (SE) 2022-02-15 — — US claimed
US-20210298611-A1 DETECTION OF HIGH-RISK UNSTABLE ATHEROSCLEROTIC PLAQUE VICTOR CHANG CARDIAC RES INSTITUTE (AU) 2021-09-30 — — US claimed
US-20200206226-A1 MPO INHIBITORS FOR USE IN MEDICINE ASTRAZENECA AB (SE) 2020-07-02 — — US claimed
EP-3654983-A1 MPO INHIBITORS FOR USE IN MEDICINE Astrazeneca AB (SE) 2020-05-27 — — EP claimed
CN-110891572-A MPO inhibitors for use in medicine 阿斯利康(瑞典)有限公司 2020-03-17 — — CN claimed
WO-2019016074-A1 MPO INHIBITORS FOR USE IN MEDICINE ASTRAZENECA AB (SE) 2019-01-24 — — WO claimed
US-20080312311-A1 Crystalline forms of 3-(2R-tetrahydrofuryl-methyl)-2-thioxanthine ASTRAZENECA AB (SE) 2008-12-18 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200206226-A1 MPO INHIBITORS FOR USE IN MEDICINE MPO, SERPINB1, MMP8 MPO 1/4885TPO 23/4885ALDH1A1 466/4885
US-11246870-B2 MPO inhibitors for use in medicine MPO, SERPINB1, MMP8 MPO 1/4885TPO 23/4885ALDH1A1 466/4885
US-20220160715-A1 MPO INHIBITORS FOR USE IN MEDICINE MPO, SERPINB1, MMP8 MPO 1/4885TPO 23/4885ALDH1A1 466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback